Amphastar Pharmaceuticals, Inc. (AMPH) earnings

Earnings (net income) · fiscal 2025
$98.09M

Amphastar Pharmaceuticals, Inc. (AMPH) reported net income of $98.09M in fiscal 2025 (the year ended December 31, 2025). That is 38.5% lower than the $159.52M of fiscal 2024. Figures as of 18 Nov 2026, 12:56 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Earnings (net income), fiscal 2025
$98.09M
Change on fiscal 2024
−38.5%
Growth, 5 years
+133.8% a year
Highest on record
$159.52Mfiscal 2024
Lowest on record
-$10.70Mfiscal 2014
Fiscal years on record
142012–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Amphastar Pharmaceuticals, Inc. earnings, in more detail

Over the five fiscal years to 2025 net income grew at a compound 133.8% a year. Across the 14 fiscal years on record (2012–2025), the highest was $159.52M in fiscal 2024 and the lowest -$10.70M in fiscal 2014.

History · 14 fiscal years

Earnings (net income) by fiscal year

Amphastar Pharmaceuticals, Inc. earnings, year by year

Amphastar Pharmaceuticals, Inc. (AMPH) earnings by fiscal year
Fiscal yearEarnings (net income)ChangeYear ended
2025$98.09M 38.5% down
2024$159.52M 16.0% up
2023$137.55M 50.5% up
2022$91.39M 47.1% up
2021$62.12M 4,327.4% up
2020$1.40M 97.1% down
2019$48.94M—
2018-$5.74M 257.3% down
2017$3.65M 62.9% down
2016$9.82M—
2015-$2.79M—
2014-$10.70M 190.2% down
2013$11.86M 34.4% down
2012$18.09M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Earnings here means net income: what is left of the year's revenue after every cost, interest and tax, as reported on the income statement.

How to read it

Compare it across years rather than in isolation — one-off gains and write-downs can swing a single year a long way.

More on AMPH

Amphastar Pharmaceuticals, Inc., figure by figure

Amphastar Pharmaceuticals, Inc. (AMPH) overview: price, valuation and scorecard

Amphastar Pharmaceuticals, Inc. earnings: questions and answers

What is Amphastar Pharmaceuticals, Inc.'s net income?

Amphastar Pharmaceuticals, Inc. (AMPH) reported net income of $98.09M in fiscal 2025 (the year ended December 31, 2025). That is 38.5% lower than the $159.52M of fiscal 2024.

What is the growth rate of Amphastar Pharmaceuticals, Inc.'s net income?

Over the five fiscal years to 2025 net income grew at a compound 133.8% a year.

What are the highest and lowest net income figures on record for Amphastar Pharmaceuticals, Inc.?

Across the 14 fiscal years on record (2012–2025), the highest was $159.52M in fiscal 2024 and the lowest -$10.70M in fiscal 2014.

How is Amphastar Pharmaceuticals, Inc.'s net income calculated?

Earnings here means net income: what is left of the year's revenue after every cost, interest and tax, as reported on the income statement. For Amphastar Pharmaceuticals, Inc. it is on record here for 14 fiscal years, 2012 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Amphastar Pharmaceuticals, Inc. (AMPH) earnings”, data as of 18 November 2026. https://funkfolio.com/stock/AMPH/earnings

Underlying data: the company's filings with the SEC and Yahoo Finance.